TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
3D Medicines, Inc. ( (HK:1244) ) has shared an update.
3D Medicines, Inc. has entered into a Strategic Cooperation Agreement with Qingdao Hainuo, a substantial shareholder of its subsidiary, to discharge a Preservation Order imposed by the Qingdao Intermediate People’s Court. This agreement, valued at RMB98.0 million, aims to improve the company’s financial flexibility and operational efficiency by unfreezing bank accounts and facilitating smoother day-to-day operations, thereby reinforcing the company’s financial stability.
More about 3D Medicines, Inc.
3D Medicines, Inc. operates in the pharmaceutical industry, focusing on developing innovative medical solutions. The company is involved in strategic partnerships and collaborations to enhance its market presence and operational efficiency.
Average Trading Volume: 207,779
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.04B
Learn more about 1244 stock on TipRanks’ Stock Analysis page.